PortfoliosLab logo
RXT vs. SYRE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between RXT and SYRE is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

RXT vs. SYRE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Rackspace Technology, Inc. (RXT) and Spyre Therapeutics Inc. (SYRE). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

RXT:

-0.56

SYRE:

-0.80

Sortino Ratio

RXT:

-0.54

SYRE:

-0.98

Omega Ratio

RXT:

0.94

SYRE:

0.89

Calmar Ratio

RXT:

-0.41

SYRE:

-0.56

Martin Ratio

RXT:

-1.35

SYRE:

-1.32

Ulcer Index

RXT:

29.35%

SYRE:

40.76%

Daily Std Dev

RXT:

69.23%

SYRE:

69.79%

Max Drawdown

RXT:

-95.86%

SYRE:

-99.12%

Current Drawdown

RXT:

-95.63%

SYRE:

-94.90%

Fundamentals

Market Cap

RXT:

$270.62M

SYRE:

$922.20M

EPS

RXT:

-$1.22

SYRE:

-$3.06

PS Ratio

RXT:

0.10

SYRE:

650.22

PB Ratio

RXT:

0.81

SYRE:

2.82

Total Revenue (TTM)

RXT:

$2.71B

SYRE:

$0.00

EBITDA (TTM)

RXT:

$79.90M

SYRE:

-$214.36M

Returns By Period

In the year-to-date period, RXT achieves a -48.42% return, which is significantly lower than SYRE's -34.36% return.


RXT

YTD

-48.42%

1M

-17.39%

6M

-57.46%

1Y

-41.84%

3Y*

-50.20%

5Y*

N/A

10Y*

N/A

SYRE

YTD

-34.36%

1M

4.23%

6M

-46.25%

1Y

-56.28%

3Y*

-27.14%

5Y*

-41.35%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Rackspace Technology, Inc.

Spyre Therapeutics Inc.

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

RXT vs. SYRE — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RXT
The Risk-Adjusted Performance Rank of RXT is 1919
Overall Rank
The Sharpe Ratio Rank of RXT is 1919
Sharpe Ratio Rank
The Sortino Ratio Rank of RXT is 2121
Sortino Ratio Rank
The Omega Ratio Rank of RXT is 2323
Omega Ratio Rank
The Calmar Ratio Rank of RXT is 2424
Calmar Ratio Rank
The Martin Ratio Rank of RXT is 1010
Martin Ratio Rank

SYRE
The Risk-Adjusted Performance Rank of SYRE is 1313
Overall Rank
The Sharpe Ratio Rank of SYRE is 99
Sharpe Ratio Rank
The Sortino Ratio Rank of SYRE is 1212
Sortino Ratio Rank
The Omega Ratio Rank of SYRE is 1414
Omega Ratio Rank
The Calmar Ratio Rank of SYRE is 1515
Calmar Ratio Rank
The Martin Ratio Rank of SYRE is 1212
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

RXT vs. SYRE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Rackspace Technology, Inc. (RXT) and Spyre Therapeutics Inc. (SYRE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current RXT Sharpe Ratio is -0.56, which is comparable to the SYRE Sharpe Ratio of -0.80. The chart below compares the historical Sharpe Ratios of RXT and SYRE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

RXT vs. SYRE - Dividend Comparison

Neither RXT nor SYRE has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

RXT vs. SYRE - Drawdown Comparison

The maximum RXT drawdown since its inception was -95.86%, roughly equal to the maximum SYRE drawdown of -99.12%. Use the drawdown chart below to compare losses from any high point for RXT and SYRE.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

RXT vs. SYRE - Volatility Comparison

The current volatility for Rackspace Technology, Inc. (RXT) is 17.77%, while Spyre Therapeutics Inc. (SYRE) has a volatility of 20.70%. This indicates that RXT experiences smaller price fluctuations and is considered to be less risky than SYRE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

RXT vs. SYRE - Financials Comparison

This section allows you to compare key financial metrics between Rackspace Technology, Inc. and Spyre Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M20212022202320242025
665.40M
0
(RXT) Total Revenue
(SYRE) Total Revenue
Values in USD except per share items